Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Catherine Tak Piech"'
Autor:
Diana M Sobieraj, Craig I Coleman, Erin R. Weeda, Catherine Tak Piech, Elaine Nguyen, Brahim Bookhart
Publikováno v:
Current Medical Research and Opinion. 32:1281-1290
Objective: To evaluate current knowledge of the impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior. Methods: The literature was searched (Medline and Web of Science, January 2000–N
Publikováno v:
Decision Making in a World of Comparative Effectiveness Research ISBN: 9789811032615
Comparative effectiveness research (CER) is the process of examining the performance of various medical treatments against each other. Many factors can affect how CER is performed and what conclusions are derived from any given study. Though the gold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c66524d2a31b7af6ae5a4e663868704
https://doi.org/10.1007/978-981-10-3262-2_5
https://doi.org/10.1007/978-981-10-3262-2_5
Autor:
Mekre Senbetta, R. Scott McKenzie, Catherine Tak Piech, Kay Larholt, Chris L. Pashos, Kimberly A. Fraser
Publikováno v:
Supportive Care in Cancer
Purpose To assess the clinical and economic outcomes among patients with chemotherapy-induced anemia (CIA) treated with United States Food and Drug Administration-approved fixed dosing regimens of erythropoiesis-stimulating agents (ESA). Methods Data
Autor:
Francis Vekeman, Robert A. Bailey, Nadege-Desiree Yameogo, R. Scott McKenzie, Patrick Lefebvre, Catherine Tak Piech
Publikováno v:
Journal of Medical Economics. 13:673-680
To compare the healthcare costs of pre-dialysis chronic kidney disease (CKD) patients cared for in a nephrology clinic setting versus other care settings.An analysis of health claims between 01/2002 and 09/2007 from the Ingenix Impact Database was co
Publikováno v:
PharmacoEconomics. 28:923-930
Autor:
Robert A. Bailey, Catherine Tak Piech, Brett S. Kilpatrick, Patrick Lefebvre, Francis Vekeman, Mekre Senbetta, Marie-Hélène Lafeuille
Publikováno v:
The Consultant Pharmacist. 25:493-500
OBJECTIVE To compare drug-utilization patterns and costs in patients with chronic kidney disease (CKD), not on dialysis, yet receiving epoetin alfa (EPO) or darbepoetin alfa (DARB) in a long-term care setting. DESIGN A retrospective analysis of pharm
Autor:
Catherine Tak Piech, R. Scott McKenzie, Brahim Bookhart, Tanya Burton, Chris L. Pashos, David C. Hoaglin, Mitra Corral, Kay Larholt
Publikováno v:
Community Oncology. 6:403-408
Autor:
Catherine Tak Piech, Tina Greco, Mei Sheng Duh, Sue H. Watson, Samir H. Mody, Yoon Jun Kang, Harminder Sikand, Ayesha Naeem, Adam Decter
Publikováno v:
Annals of Pharmacotherapy. 42:16-23
Background: Unlike in outpatient settings, the comparative costs of epoetin alfa (EPO) and darbepoetin alfa (DARB) have not been evaluated broadly from the inpatient hospital perspective. Objective: To develop a cost analytic model comparing hospital
Autor:
Kay Larholt, Brahim Bookhart, Catherine Tak Piech, R. Scott McKenzie, Qin Wang, Chris L. Pashos
Publikováno v:
Clinical Drug Investigation. 28:159-167
To report the design, methodology, implementation and initial results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry, the first US patient registry to collect and report on practice patterns and outcomes asso
Autor:
Brahim Bookhart, Jeffrey Hymes, James H. Jackson, Samir H. Mody, Tammy Bickimer, Catherine Tak Piech
Publikováno v:
Current Medical Research and Opinion. 23:1931-1937
To compare real-world dosing patterns, drug costs, and hematologic outcome in anemic chronic kidney disease (CKD) patients, not receiving dialysis, who switched from darbepoetin alfa (DARB) to epoetin alfa (EPO) in a community practice setting.This r